XP Inc.

XP (ticker: XP, trading currency: USD) is a scaled Brazilian wealth platform whose core engine is still healthy, but it has matured from hypergrowth into a more rate- and market-sensitive compounding story. Latest primary data used: FY2025 (year ended December 31, 2025).

The DNA is straightforward: XP gathers client assets onto its platform, then monetizes those assets multiple ways. It earns distribution fees and commissions on investment products, advisory and platform fees, asset-management revenues, trading revenues, issuer/capital-markets fees, and increasingly banking/credit/insurance income. The key point is that XP is not just “a broker.” It is a distribution machine plus a product shelf plus an advisor network. If assets stay, client activity stays, and wallet share rises, revenue compounds without needing a branch-heavy bank cost structure.

That engine is more durable than it first appears, because the real asset is the relationship layer: independent advisors, product breadth, brand, and client trust. But it is also less predictable than top-tier global exchanges or data vendors because monetization depends on Brazilian interest rates, market sentiment, and product mix. When risk appetite weakens, trading, fund distribution, and higher-take-rate products can all soften.

On balance, the economics look moderately strengthening structurally, but not linearly. XP keeps broadening from transactional revenues toward more recurring revenues tied to assets, advisory, and banking. That is good. What would worry me is not short-term market volatility; it would be stalling net inflows, declining active clients or advisor productivity, falling revenue per asset, or evidence that clients are migrating back to incumbent banks or low-fee passive channels.

It is mostly a win-win model when XP lowers friction and expands product access for Brazilian savers. The caveat is familiar in wealth distribution: if growth relies too heavily on pushing higher-margin products rather than client outcomes, trust erodes and the moat weakens.

If I could track only five numbers, they would be: assets on platform/custody, net inflows, active clients, revenue take-rate on client assets, and recurring-revenue mix.

Conclusion: XP’s market is still a medium-term tailwind: Brazilian savings continue to migrate from bank-led, closed architecture toward open-architecture investing and advice, but the easy share-gain phase is over and competition is now structurally tougher.

As of the latest official data used (FY2025), this is a good market, not a pristine one: large, under-advised, and still shifting structurally in XP’s favor, but with pricing pressure and adviser churn likely to keep returns from looking effortless.

XP has a real but not deep moat: scale distribution in Brazilian investments, reinforced by product breadth and advisor-led client relationships, but constrained by low structural pricing power and rising competition from banks and digital platforms. As of FY2025, the moat looks stable, not clearly widening.

The key distinction: XP’s moat is mostly distribution, process and embedded relationships, not patents, toll-bridge economics or premium pricing. That is durable enough to matter, but not strong enough to make the business competitively untouchable.

Conclusion: XP’s finances are sound, but not bulletproof. This is a well-capitalized, profitable wealth platform with decent cash generation and no obvious accounting blow-up, yet its earnings power remains meaningfully tied to market activity, rates, and spread conditions. Most recent official data used: FY2025 (December 31, 2025).

Bottom line: financially solid enough to survive a downturn, but not clean enough to merit a top-tier balance-sheet score.

XP still has reinvestment room, but the runway is good rather than great. The core wealth platform remains asset-light and benefits from a still-underpenetrated Brazilian investment market, so XP can keep compounding through net new client assets, deeper wallet share, pensions, insurance, and selected banking products. The constraint is not demand; it is marginal return compression as the base gets larger and newer verticals are more capital-intensive than the original brokerage/advisory engine.

A reasonable base case is high-single to low-double-digit organic growth over time: client asset growth plus modest monetization gains, offset by cyclicality in trading/activity revenues. XP can likely reinvest retained earnings at returns above its cost of capital, but probably below the very high returns of its earlier scaling phase.

Bottom line: XP has a moderate reinvestment runway. The business can still redeploy capital productively, but future incremental returns are likely to be lower than past headline ROIC.

Peer Comparison

XP remains a domestic leader in independent wealth distribution, but it is no longer a category-of-one; it is still taking share from incumbent banks, just at a slower and more contested pace than a few years ago. Using the most recent reported data available (FY2025, year ended December 31, 2025), XP’s edge is still its advisor-led open architecture and broad product shelf. In Brazil, the closest peers are BTG Pactual, Itaú/ION, Safra, Banco Inter, and increasingly Nubank at the mass-affluent entry point. Globally, the best analogs are Charles Schwab and Interactive Brokers: platforms monetizing client assets, trading, advice, and cash.

XP is probably still gaining share, but mainly by deepening wallet share and advisor productivity, not by easy greenfield land-grabs. Outlook: positive, but incremental gains should be harder as incumbents improve digital advice and pricing.

Conclusion: XP looks founder-aligned but not minority-perfect. The key positive is real insider control: Guilherme Benchimol and the founding group still matter economically and, more importantly, control the vote through the Class B structure. The key negative is the same fact: outside holders are partners, but not equals.

The 2025 20-F shows a dual-class setup with 415368323 Class A and 103375726 Class B shares outstanding at year-end 2025; that structure preserves insider influence well beyond pure economic ownership. That usually helps long-term decision-making, but it also weakens the market’s ability to discipline management. So alignment is better than a hired-manager model, worse than one-share/one-vote governance.

I do not see evidence in the reviewed primary filing of a major, thesis-breaking enforcement action against XP leadership, nor an obvious pattern of abusive related-party extraction. Formal governance looks adequate for a large foreign private issuer, but concentrated control means investors are still underwriting trust in the controller. Recent open-market insider buy/sell signaling is not clearly disclosed in the materials reviewed, so I would not lean on insider trading as a bullish indicator. Capital return is decent, not exceptional.

XP’s management looks capable and mostly shareholder-aware, but not elite on governance. The core record is value creation through organic buildout: management turned XP from a brokerage challenger into Brazil’s leading independent wealth platform, widened monetization, and avoided the kind of large, obviously value-destructive M&A that often ruins financial firms. Execution has been real, though not flawless: recent years exposed how sensitive activity and monetization are to rates and market mood, so the record is stronger on strategic expansion than on smoothing earnings.

On ethics/transparency, the latest 20-F is more reassuring than exciting. It discloses effective internal controls, no error-correction restatement, and no auditor disagreement. I do not see evidence here of a major accounting blow-up or litigation issue that changes the long-term thesis. The main discount is governance complexity: founder influence and related-party/controlled-company optics mean investors should demand some skepticism, even without a clear fraud signal.

XP looks modestly undervalued, not dramatically cheap. At a USD 16.35B market cap and 13.1x forward P/E, the market is pricing XP like a decent-but-cyclical broker, not a platform that can likely compound earnings at low-teens rates if Brazilian wealth penetration keeps rising.

The right framework is normalized earnings / ROE, not DCF or liquidation value. XP’s balance sheet is that of a financial intermediary: the huge cash and debt figures are mostly operating balances, so liquidation value is anchored far more by equity/tangible equity than by gross assets. On FY2025 numbers, common equity was about R$23.6B and tangible book about R$20.8B; shareholders would not get anything close to gross cash in a wind-down.

Management has historically pushed operating targets around client assets, engagement, and platform breadth more than hard multi-year EPS guidance. That makes guidance only moderately credible as a valuation anchor. What is credible is the record: 2022-2025 net income rose from R$3.58B to R$5.17B, while shares outstanding drifted down, supporting EPS growth even through a mixed macro tape. If XP can deliver roughly 11-12% annual EPS growth through 2031 and still deserve only 14x P/E, equity value lands around USD 29B. That is my intrinsic value estimate.

The current price implies something closer to high-single-digit normalized earnings growth and/or a permanently compressed multiple. That feels too pessimistic unless Brazil’s capital-markets development structurally stalls.

Conclusion: XP can probably compound acceptably from here, but this is not a “set-and-forget elite compounder.” The moat looks durable for years, not impregnable for decades.

XP’s best long-term asset is its distribution system: advisor network, brand with affluent Brazilian savers, and a broad product shelf that monetizes client assets multiple ways. That should keep it relevant in 10–20 years unless regulation materially weakens the independent-advisor model or competitors match XP’s economics while undercutting price. Using FY2025 as the latest full-year anchor, the business still looks healthy enough to support a roughly 2–3x value outcome over 10 years if Brazilian wealth penetration keeps rising and XP keeps taking share.

The reinvestment story is decent, not extraordinary. Reinvesting into advisor productivity, banking adjacency, and cross-sell can still widen the moat. But incremental returns likely fade if growth shifts toward more balance-sheet-heavy credit and banking, where economics are less clean than fee-based wealth.

What breaks first is usually distribution quality, not headline revenue. The clearest thesis-break signal would be 2–3 years of weak net new money plus falling advisor productivity/client assets per advisor, showing XP is no longer the default platform for Brazil’s high-income investor.

Conclusion: XP’s risk profile is moderate, not benign. The main long-term danger is not market volatility; it is a regulatory or conduct failure that breaks trust with clients and the advisor network, because trust is the real asset here. Using FY2025 as the latest full-year data point, balance-sheet risk looks manageable; franchise and policy risk matter more than leverage.

The single most important permanent risk is a compliance-driven loss of trust. Probability is medium; impact is very high.

Final Verdict: BUY

XP is worth owning now, but not worshipping. This is a good business, not a great one: scaled distribution, strong brand in Brazilian wealth, solid returns, and a still-real reinvestment runway — offset by market sensitivity, tougher competition, and governance that deserves a discount. At USD 32.22 and roughly USD 16.35 billion market cap, the stock still looks priced more like a cyclical broker than a durable wealth platform.

The core question is not whether earnings will be smooth. They will not. The real question is whether XP is likely to suffer permanent capital impairment over 5-10 years. I think the answer is probably not, unless it trips on regulation, conduct, or advisor-network trust. That is the key inversion test: how does this thesis fail? Not through a normal Brazilian cycle, but through a reputational or regulatory break that weakens client asset gathering and compresses the platform’s economics.

XP is not an exceptional compounder. The moat is real but only moderate; pricing power is limited; competition from BTG, incumbents, and digital channels is no longer soft. But it still earns attractive returns, grew earnings and cash generation through FY2025, and remains one of the few scaled independent wealth franchises in Brazil. That is enough at this valuation.

So the right posture is: buy, but in tranches. This is not a “load the truck” situation. The upside looks good enough for above-average returns, but conviction is not high enough to justify concentration. For existing holders, the right move is buy more modestly / hold firmly, not trim just because the stock has rallied. Also, do not underwrite the quoted 66% dividend yield; that figure is almost certainly distorted by special distributions and data handling.

Is the analysis accurate and complete? Not fully. Research further:

• Advisor productivity, retention, and net new money by channel
• Mix shift toward banking/credit and whether returns dilute over time
• Any regulatory or conduct issues that could impair trust
• Whether competitive pricing is structurally compressing take rates